Zobrazeno 1 - 10
of 15
pro vyhledávání: '"John, Boockvar"'
Autor:
Muhammad Babar Khan, Rosamaria Ruggieri, Eesha Jamil, Nhan L. Tran, Camila Gonzalez, Nancy Mugridge, Steven Gao, Jennifer MacDiarmid, Himanshu Brahmbhatt, Jann N. Sarkaria, John Boockvar, Marc Symons
Publikováno v:
Molecular Medicine, Vol 27, Iss 1, Pp 1-17 (2021)
Abstract Background Glioblastoma is the most common primary brain tumor and remains uniformly fatal, highlighting the dire need for developing effective therapeutics. Significant intra- and inter-tumor heterogeneity and inadequate delivery of therape
Externí odkaz:
https://doaj.org/article/c1a6ee476fc8474f99b9f1bb007fbe07
Autor:
Mayu O. Frank, Takahiko Koyama, Kahn Rhrissorrakrai, Nicolas Robine, Filippo Utro, Anne-Katrin Emde, Bo-Juen Chen, Kanika Arora, Minita Shah, Heather Geiger, Vanessa Felice, Esra Dikoglu, Sadia Rahman, Alice Fang, Vladimir Vacic, Ewa A. Bergmann, Julia L. Moore Vogel, Catherine Reeves, Depinder Khaira, Anthony Calabro, Duyang Kim, Michelle F. Lamendola-Essel, Cecilia Esteves, Phaedra Agius, Christian Stolte, John Boockvar, Alexis Demopoulos, Dimitris G. Placantonakis, John G. Golfinos, Cameron Brennan, Jeffrey Bruce, Andrew B. Lassman, Peter Canoll, Christian Grommes, Mariza Daras, Eli Diamond, Antonio Omuro, Elena Pentsova, Dana E. Orange, Stephen J. Harvey, Jerome B. Posner, Vanessa V. Michelini, Vaidehi Jobanputra, Michael C. Zody, John Kelly, Laxmi Parida, Kazimierz O. Wrzeszczynski, Ajay K. Royyuru, Robert B. Darnell
Publikováno v:
BMC Medical Genomics, Vol 12, Iss 1, Pp 1-16 (2019)
Abstract Background Prompted by the revolution in high-throughput sequencing and its potential impact for treating cancer patients, we initiated a clinical research study to compare the ability of different sequencing assays and analysis methods to a
Externí odkaz:
https://doaj.org/article/11a5273709844f08a3cc53b25ce39717
Autor:
Michelle De Witt, Alexander Gamble, Derek Hanson, Daniel Markowitz, Caitlin Powell, Saleh Al Dimassi, Mark Atlas, John Boockvar, Rosamaria Ruggieri, Marc Symons
Publikováno v:
Molecular Medicine, Vol 23, Iss 1, Pp 50-56 (2017)
Abstract The microtubule inhibitor vincristine is currently used to treat a variety of brain tumors, including low-grade glioma and anaplastic oligodendroglioma. Vincristine, however, does not penetrate well into brain tumor tissue, and moreover, it
Externí odkaz:
https://doaj.org/article/23f5ae1dbd7c45a4a3d2781470897b97
Autor:
Omer Doron, Tom Chen, Tamika Wong, Amy Tucker, Peter Costantino, Robert Andrews, David J. Langer, John Boockvar
Publikováno v:
Neurosurgical Review. 45:2481-2487
Glioblastoma multiforme (GBM) patients continue to suffer a poor prognosis. The blood brain barrier (BBB) comprises one of the obstacles for therapy, creating a barrier that decreases the bioavailability of chemotherapeutic agents in the central nerv
Autor:
Mayu O. Frank, Takahiko Koyama, Kahn Rhrissorrakrai, Nicolas Robine, Filippo Utro, Anne-Katrin Emde, Bo-Juen Chen, Kanika Arora, Minita Shah, Heather Geiger, Vanessa Felice, Esra Dikoglu, Sadia Rahman, Xiaolan Fang, Vladimir Vacic, Ewa A. Bergmann, Julia L. Moore Vogel, Catherine Reeves, Depinder Khaira, Anthony Calabro, Duyang Kim, Michelle F. Lamendola-Essel, Cecilia Esteves, Phaedra Agius, Christian Stolte, John Boockvar, Alexis Demopoulos, Dimitris G. Placantonakis, John G. Golfinos, Cameron Brennan, Jeffrey Bruce, Andrew B. Lassman, Peter Canoll, Christian Grommes, Mariza Daras, Eli Diamond, Antonio Omuro, Elena Pentsova, Dana E. Orange, Stephen J. Harvey, Jerome B. Posner, Vanessa V. Michelini, Vaidehi Jobanputra, Michael C. Zody, John Kelly, Laxmi Parida, Kazimierz O. Wrzeszczynski, Ajay K. Royyuru, Robert B. Darnell
Publikováno v:
BMC Medical Genomics, Vol 12, Iss 1, Pp 1-1 (2019)
Following publication of the original article [1], it was reported that the given name of the fourteenth author was incorrectly published. The incorrect and the correct names are given below.
Externí odkaz:
https://doaj.org/article/1d97177535aa4c4aae7304b51c8609fd
Publikováno v:
Neuro-Oncology. 24:vii44-vii44
Introduction Glioblastoma (GBM) is the most common primary brain malignancy in adults. The vast majority of GBM cases maintain wild-type status of p53, the protein considered to be the most critical tumor suppressor. How GBM displays such a malignant
Autor:
Tristan Tham, Peter Costantino, Margherita Bruni, David Langer, John Boockvar, Prabhjyot Singh
Publikováno v:
Journal of Neurological Surgery Reports, Vol 76, Iss 02, Pp e291-e296 (2015)
Abstract Introduction Historically, access to the anterior skull base was achieved with open procedures. The paradigms to this approach were challenged with the advent of minimally disruptive endoscopic surgical techniques and supporting technology
Externí odkaz:
https://doaj.org/article/470b4516e6d44f8a83866c94727eef17
Autor:
Jacob D, Greisman, Zachary T, Olmsted, Patrick J, Crorkin, Colin A, Dallimore, Vadim, Zhigin, Artur, Shlifer, Anupama D, Bedi, Jane K, Kim, Priscilla, Nelson, Heustein L, Sy, Kiran V, Patel, Jason A, Ellis, John, Boockvar, David J, Langer, Randy S, D'Amico
Publikováno v:
World Neurosurgery. 163:104-122.e2
Enhanced Recovery After Surgery (ERAS) protocols describe a standardized method of preoperative, perioperative, and postoperative care to enhance outcomes and minimize complication risks surrounding elective surgical intervention. A growing body of e
Autor:
Jann N. Sarkaria, Rosamaria Ruggieri, Himanshu Brahmbhatt, Jennifer Macdiarmid, Muhammad Babar Khan, Marc Symons, John Boockvar, Nhan L. Tran
Publikováno v:
Neuro Oncol
Therapeutic resistance stemming from inter and intra-tumoral heterogeneity is a significant impediment towards development of effective therapeutics for glioblastoma. We hypothesized that microRNAs can potentially counteract resistance emanating from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b543f72a39650c437516b7f738531f
https://europepmc.org/articles/PMC6846215/
https://europepmc.org/articles/PMC6846215/
Autor:
Himanshu Brahmbhatt, Jann N. Sarkaria, Nhan L. Tran, Rosamaria Ruggieri, Marc Symons, Jennifer Macdiarmid, Muhammad Babar Khan, John Boockvar
Publikováno v:
Neuro Oncol
BACKGROUND Glioblastomas show marked intra- and inter-tumor heterogeneity and are strongly resistant to both radio- and chemo-therapy, which are standard therapeutic modalities for this tumor. MicroRNAs (miRNAs) have the potential to serve as effecti